# Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer

> **NCT05928299** · — · UNKNOWN · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 400 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05928299
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05928299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05928299, "Integrative Multi-Omics Testing for Immunotherapy Response in Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05928299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*